Cargando…

Cross-reactivity towards SARS-CoV-2: the potential role of low-pathogenic human coronaviruses

Detalles Bibliográficos
Autores principales:	Ma, Zhongren, Li, Pengfei, Ji, Yuepeng, Ikram, Aqsa, Pan, Qiuwei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Author(s). Published by Elsevier Ltd. 2020
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7836609/ https://www.ncbi.nlm.nih.gov/pubmed/33521716 http://dx.doi.org/10.1016/S2666-5247(20)30098-7

Ejemplares similares

Does Cross-neutralization of SARS-CoV-2 Only Relate to High Pathogenic Coronaviruses?
por: Ma, Zhongren, et al.
Publicado: (2020)

Estimating Global Epidemiology of Low-Pathogenic Human Coronaviruses in Relation to the COVID-19 Context
por: Li, Pengfei, et al.
Publicado: (2020)

Potential association between COVID-19 mortality and health-care resource availability
por: Ji, Yunpeng, et al.
Publicado: (2020)

SARS-CoV-2 serological cross-reactivity with autoantibodies
por: Choy, Kay Weng
Publicado: (2021)

Humoral cross-reactivity towards SARS-CoV-2 in young children with acute respiratory infection with low-pathogenicity coronaviruses
por: Dhochak, Nitin, et al.
Publicado: (2022)

SARS-CoV-2 serological cross-reactivity with autoantibodies – Authors' reply
por: Teng, Jialin, et al.
Publicado: (2021)

Treating SARS-CoV-2 Omicron variant infection by molnupiravir for pandemic mitigation and living with the virus: a mathematical modeling study
por: Zheng, Qinyue, et al.
Publicado: (2023)

Specificity and cross-reactivity of a test for anti-SARS-CoV-2 antibodies
por: Choy, Kay Weng
Publicado: (2021)

Cross-reactive antibody immunity against SARS-CoV-2 in children and adults
por: Fraley, Elizabeth, et al.
Publicado: (2021)

Impact of SARS-CoV-2 envelope protein mutations on the pathogenicity of Omicron XBB
por: Wang, Yi, et al.
Publicado: (2023)

Specificity and cross-reactivity of a test for anti-SARS-CoV-2 antibodies – Authors' reply
por: Iversen, Kasper, et al.
Publicado: (2021)

HEV prevalence and potential risk factors in a large multi-ethnic youth cohort in China
por: Li, Huixia, et al.
Publicado: (2021)

Repurposing dyphylline as a pan-coronavirus antiviral therapy
por: Wang, Yining, et al.
Publicado: (2022)

Estimating the global prevalence of hepatitis E virus in swine and pork products
por: Li, Pengfei, et al.
Publicado: (2021)

Distinct effectiveness in containing COVID-19 epidemic: Comparative analysis of two cities in China by mathematical modeling
por: Ji, Yunpeng, et al.
Publicado: (2021)

Cross-Reactive Neutralizing Antibody Responses Elicited by SARS-CoV-2 501Y.V2 (B.1.351)
por: Moyo-Gwete, Thandeka, et al.
Publicado: (2021)

Viral polymerase binding and broad-spectrum antiviral activity of molnupiravir against human seasonal coronaviruses
por: Wang, Yining, et al.
Publicado: (2021)

Differing pan-coronavirus antiviral potency of boceprevir and GC376 in vitro despite discordant molecular docking predictions
por: Wang, Yining, et al.
Publicado: (2022)

Temporal antibody responses to SARS-CoV-2 in patients of coronavirus disease 2019
por: Huang, Min, et al.
Publicado: (2020)

Arthritis after SARS-CoV-2 infection: reactive arthritis or virally mediated arthritis?
por: Baimukhamedov, Chokan, et al.
Publicado: (2022)

Immunization with the receptor-binding domain of SARS-CoV-2 elicits antibodies cross-neutralizing SARS-CoV-2 and SARS-CoV without antibody-dependent enhancement
por: Zang, Jinkai, et al.
Publicado: (2020)

Low seroprevalence of SARS-CoV-2 antibodies in cirrhotic patients
por: Del Zompo, Fabio, et al.
Publicado: (2021)

Risk of hepatitis B reactivation associated with treatment against SARS-CoV-2 (COVID-19) with corticosteroids()
por: Varona Pérez, J., et al.
Publicado: (2020)

The Impact of Mutations on the Pathogenic and Antigenic Activity of SARS-CoV-2 during the First Wave of the COVID-19 Pandemic: A Comprehensive Immunoinformatics Analysis
por: Baloch, Zulqarnain, et al.
Publicado: (2021)

Comparative assessment of favipiravir and remdesivir against human coronavirus NL63 in molecular docking and cell culture models
por: Wang, Yining, et al.
Publicado: (2021)

Novel coronavirus outbreak in Pakistan: Beware of dengue
por: Rana, Muhammad Suleman, et al.
Publicado: (2021)

Pre-existing humoral immunity to low pathogenic human coronaviruses exhibits limited cross-reactive antibodies response against SARS-CoV-2 in children
por: Li, Nina, et al.
Publicado: (2022)

Systematically comparing COVID-19 with the 2009 influenza pandemic for hospitalized patients
por: Li, Pengfei, et al.
Publicado: (2021)

Paleoserology points to Coronavirus as possible causative pathogens of the ‘Russian flu’
por: Ramassy, Lindsay, et al.
Publicado: (2022)

Scleredema developing after SARS-CoV2 infection: a possible novel skin manifestation of coronavirus disease
por: Sánchez-Díaz, Manuel, et al.
Publicado: (2022)

Low risk of SARS-CoV-2 transmission by fomites in real-life conditions
por: Mondelli, Mario U, et al.
Publicado: (2021)

Comparing SARS-CoV-2 with SARS-CoV and influenza pandemics
por: Standl, Fabian, et al.
Publicado: (2021)

Monitoring and managing SARS-CoV-2 evolution in immunocompromised populations
por: Li, Pengfei, et al.
Publicado: (2022)

Overwhelming COVID-19 Clinical Trials: Call for Prospective Meta-Analyses
por: Ma, Zhongren, et al.
Publicado: (2020)

Questions about comparative genomics of SARS coronavirus isolates
por: Wood, Lowell
Publicado: (2003)

Attitudes of vaccination service providers to the SARS-CoV-2 intranasal spray vaccine during the SARS-CoV-2 pandemic in China: A cross-sectional study
por: Cao, Yanlin, et al.
Publicado: (2023)

Hepatitis B virus reactivation during severe acute respiratory syndrome coronavirus-2 infection
por: Tyng-Yuan, Jang
Publicado: (2023)

Prevention of SARS-CoV-2 infection in patients with decompensated cirrhosis
por: Xiao, Yong, et al.
Publicado: (2020)

Comparative genetic analysis of the novel coronavirus (2019-nCoV/SARS-CoV-2) receptor ACE2 in different populations
por: Cao, Yanan, et al.
Publicado: (2020)

Successful ABO-incompatible kidney transplantation and SARS-CoV-2–specific immune monitoring in a patient recovered from coronavirus infection
por: Hong, Su Yeon, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1k6553dk804kfcg9mb645henec